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pression of PAS, Ki67, K10 and K13, however, appeared to be 
different in TEM compared to NNOM. Nevertheless, the sim-
ilarities with native oral mucosa makes TEM a promising tool 
for studying the biology of mucosal pathologies such as 
oral mucositis or fibrosis as well as the development of new 
therapies.  Copyright © 2011 S. Karger AG, Basel 
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 Abstract 
 The aim of this study was to create and characterize a tissue-
engineered mucosal equivalent (TEM) that closely resem-
bles native mucosa. TEM consists of human primary kerati-
nocytes and fibroblasts isolated from biopsies taken from 
healthy donors and seeded onto a de-epidermized dermis 
and cultured for 14 days at the air/liquid interface. The struc-
ture of TEM was examined and compared with native non-
keratinizing oral mucosa (NNOM). The various components 
of the newly formed epidermal layer, basement membrane 
and underlying connective tissue were analyzed using im-
munohistochemistry. The mucosal substitute presented in 
this study showed a mature stratified squamous epithelium 
that was similar to that of native oral mucosa, as demon-
strated by K19, desmoglein-3 and involucrin staining. In ad-
dition, the expression of basement membrane components 
collagen type IV, laminin-5 and integrin   6 and   4 in TEM 
proved to be consistent with native oral mucosa. The ex-
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Abbreviations used in this paper
BM basement membrane
BSA bovine serum albumin
DED de-epidermized dermis
EDTA ethylenediaminetetraacetic acid
EGF epidermal growth factor
FCS fetal calf serum
KGF keratinocyte growth factor
NNOM nonkeratinizing native oral mucosa
PAS periodic acid-Schiff
PBS phosphate-buffered saline
PI proliferation index
TEM tissue-engineered mucosal substitutes
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 Introduction 
 Tissue engineering of oral mucosa is a promising tech-
nique for studying the biology and pathology of oral mu-
cosa, and can be used as a model to study the dynamics 
of wound healing [Boyce and Warden, 2002], fibrosis 
[Wang et al., 2009] and to test cytotoxicity and the work-
ing mechanisms of new treatments [Klausner et al., 2007]. 
Next to these in vitro applications, tissue-engineered mu-
cosal constructs might be used in a clinical setting to pro-
vide an alternative source for mucosal grafts for the re-
construction of large oral defects which form a major 
challenge in reconstructive surgery [Lauer and Schim-
ming, 2001; Izumi et al., 2003].
 To serve the above-described purposes, tissue-engi-
neered mucosal substitutes (TEM) should mimic native 
oral mucosa. Structural features of the tissue such as the 
presence of a multilayered epidermis, basal layer, base-
ment membrane (BM) and underlying connective tissue 
as well as the expression pattern of cytokeratins should 
resemble that of native oral mucosa. Several studies have 
reported the development of mucosal substitutes, but 
only few of them included a histological characterization 
of the construct [Izumi et al., 2004; Rakhorst et al., 2006; 
Kinikoglu et al., 2009]. Izumi et al. [2004] described the 
proliferative capacity and keratin 10 (K10)/13 (K13) ex-
pression of their mucosal substitutes, and Garzon et al. 
[2009] reported on the cytokeratin pattern in tissue-en-
gineered periodontal mucosa. Other studies described 
the pattern of cytokine release of mucosal substitutes [Xu 
et al., 2009] or the use of a variety of scaffolds to create 
TEM [Moharamzadeh et al., 2008]. All these studies fo-
cussed on some components of the construct, but to our 
knowledge none of them describe a detailed characteriza-
tion of the mucosal construct.
 The aim of the work described here was to engineer 
and thoroughly characterize a mucosal substitute that 
resembles nonkeratinizing native oral mucosa (NNOM). 
This TEM consists of primary human keratinocytes and 
fibroblasts isolated from oral mucosa and seeded onto 
de-epidermized dermis (DED). DED was chosen over 
collagen-based scaffolds for its resemblance to native 
connective tissue, easy handling and noncontractile na-
ture. The incorporation of fibroblasts into the scaffold 
has been proven to be essential for epidermal develop-
ment [El Ghalbzouri et al., 2002a], as they stimulate ke-
ratinocyte proliferation and migration by paracrine 
mechanisms [El Ghalbzouri et al., 2002b]. The TEM con-
struct was characterized by studying the expression of 
several components of the BM, the expression pattern of 
keratins, keratinocyte proliferation and differentiation. 
As cell-cell adhesion and epidermal attachment to the 
underlying connective tissue has been shown to be es-
sential for functionality [Green and Jones, 1996], the ex-
pression of desmosomes and hemidesmosomes was also 
evaluated.
 Materials and Methods 
 Chemicals and Culture Media 
 Dulbecco’s modified Eagle medium 4.5 g/l glucose (DMEM), 
Ham’s F12 culture medium, penicillin, streptomycin, gentamicin, 
amphoceterin B, dispase, collagenase type I and trypsin/ethylene-
diaminetetraacetic acid (EDTA) were purchased from Invitrogen 
(Breda, The Netherlands). Fetal calf serum (FCS) was purchased 
from PAA Laboratories (Cölbe, Germany). Bovine serum albu-
min, epidermal growth factor (EGF), keratinocyte growth factor 
(KGF) and other chemicals were purchased from Sigma-Aldrich 
(Zwijndrecht, The Netherlands). Insulin was purchased from Eli 
Lilly (Houten, The Netherlands).
 Cell Culture 
 For this study punch biopsies were taken from healthy indi-
viduals, 3 males and 1 female, all Caucasian, aged 62.75  8 6.39 
years, upon approval by the Medical Ethics Committee (No. MEC 
+ 2007-282). Half of the biopsies were snap frozen with liquid
nitrogen. The remaining biopsies were rinsed thoroughly with 
phosphate-buffered saline (PBS) and DMEM. The epidermis was 
separated from the dermis by an overnight incubation in 2.5 mg/
ml dispase solution. After rinsing the epidermal sheet with PBS, 
keratinocytes were isolated from the epidermis using 0.25% tryp-
sin-EDTA and the single cell suspension was seeded onto lethally 
irradiated 3T3 fibroblast feeder layers according to the Rheinwald 
and Green protocol [Rheinwald and Green, 1975a, b]. Culture me-
dium A consisted of a 3: 1 mixture of DMEM and Ham’s F12 me-
dium with 5% FCS, 1   M hydrocortisone, 1   M isoproterenol, 0.1 
  M insulin, 100 IU/ml penicillin, 100   g/ml streptomycin, and
1 ng/ml EGF. Fibroblasts were isolated by mincing the dermis fol-
lowed by incubation in collagenase/dispase (1.5 mg/ml/2.5 mg/
ml, respectively) solution for 2 h at 37   °   C. Next, the collagenase/
dispase solution containing the dermis was filtered twice with a 
100-  m cell strainer (Sigma-Aldrich), in order to obtain a single 
cell suspension. The isolated fibroblasts were cultured in fibro-
blast medium consisting of DMEM supplemented with 10% FCS, 
100 IU/ml penicillin and 100   g/ml streptomycin. The cells used 
in this study were within passage 3–6.
 De-Epidermized Dermis  
 Human cadaver skin, cryopreserved in 10% glycerol, and test-
ed negative for cytomegalovirus, human immunodeficiency virus 
and hepatitis B, was obtained from the European Skin Bank (Be-
verwijk, The Netherlands). The epidermis was removed from the 
dermis by gently shaking the skin in PBS supplemented with 200 
IU/ml penicillin, 200   g/ml streptomycin and 5   g/ml ampho-
tericin B. The skin was kept in the PBS solution for 3 weeks and 
PBS was changed 3 times a week.
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 Tissue-Engineered Mucosa  
 TEM was created by spinning 1  ! 10 5 fibroblasts gently into 
the lamina propria of the DED. For this procedure we used 15-ml 
tubes filled with 13 ml 1% agarose gel (Sigma-Aldrich) on which 
the DED scaffold is placed, lamina propria side upwards. Next the 
fibroblasts are placed onto the DED. The tubes containing the 
DED and fibroblasts are placed in a centrifuge and the fibroblasts 
are gently spinned into the DED, at 500 rpm for 60 min. Next, the 
DED containing the fibroblasts was placed onto a stainless steel 
grid and kept at an air/liquid interface with fibroblast medium for 
approximately 5 h to ensure cell attachment to the DED. Finally, 
the DED was flipped over and the keratinocytes were seeded onto 
the BM, and kept in a submerged condition for 24 h with medium 
A supplemented with 4 ng/ml KGF instead of EGF. After 24 h, the 
construct was raised to the air/liquid interface and medium A was 
replaced by medium B consisting of a 3: 1 mixture of DMEM and 
Ham’s F12 supplemented with 1% FCS, 24   M bovine serum al-
bumin, 1   M hydrocortisone, 1   M isoproterenol, 0.1   M insulin, 
10   M  L -carnitine, 10 m M  L -serine, 1   M  DL -  -tocopherolacetate, 
fatty acid cocktail (15   M linoleic acid, 7   M arachidonic acid and 
25   M palmitic acid), 100 IU/ml penicillin, 100   g/ml streptomy-
cin, and 4 ng/ml KGF. Medium B was removed after 48 h and re-
placed by medium C consisting of medium B in which FCS was 
omitted, linoleic acid concentration was increased to 30   M and 
50   g/ml ascorbic acid was added. Medium was changed 3 times 
a week and TEM construct was harvested after 14 days. In this 
study, keratinocytes and fibroblasts isolated from biopsies from 
different donors were never pooled.
 Morphology and Immunohistochemistry 
 Harvested TEM and NNOM biopsies were snap frozen using 
liquid nitrogen. Sections (6   m) were cut, and overall morphol-
ogy was assessed by hematoxylin-eosin and periodic acid-Schiff 
(PAS) stain. For immunohistochemical analysis of epidermal 
components K10, K13 and keratin 19 (K19), cryosections were air 
dried and fixed for 10 min in acetone. After incubation with the 
primary antibodies, frozen sections were incubated with Link/
Label complex (BioGenex, San Ramon, Calif., USA) according the 
manufacturer’s instructions. Finally, sections were stained with 
new fuchsine substrate and hematoxylin. For immunohistochem-
ical analysis of the BM and underlying connective tissue, frozen 
sections were stained for collagen type IV, laminin, involucrin, 
vimentin, desmoglein-3, integrin   6 and   4 (for antibodies and 
concentrations used in this study see  table 1 ). After incubation 
with the primary antibodies, sections were incubated with sec-
ondary antibody biotin-labelled goat anti-mouse of goat anti-rab-
bit (both 1/200, DAKO), followed by incubation with streptavi-
din-HRP (DAKO) and diaminobenzidine (DAB) substrate. The 
presence of proliferative cells was assessed using Ki67 antibody, 
using the protocol as described above. All sections were counter-
stained with hematoxylin. Controls were included with each 
staining performed. As a negative control, the primary antibody 
was replaced by PBS. For the positive control cryosections of nor-
mal oral mucosa were used. An isotope control was also included, 
for which the primary antibody was replaced by mouse anti-hu-
man IgG or rabbit anti-human IgG (DAKO), depending on the 
origin of the primary antibody it replaced. The concentration was 
similar to that of the primary antibody.
 Epidermal Thickness 
 Average epidermal thickness was determined by measuring 
the epidermis at 12 randomly selected regions for both NNOM 
and TEM, using the NDPI Viewer (Hamamatsu Photonics, 
Herrsching, Germany). This was repeated for 4 independent ex-
periments, which were done in triplicate. Statistical significance 
was determined using the Mann-Whitney U test.
 Quantification of Cell Proliferation 
 To determine the proliferation index (PI), the basal layer of the 
epithelium was analyzed. Images were taken from 12 randomly 
chosen microscopic views using 100 ! magnification. The PI was 
established as the ratio of the positive cells to all cells of the basal 
layer ( ! 100%), and results were displayed as mean  8 SD. Exper-
iments were done in triplicate. Statistical significance was deter-
mined using the Mann-Whitney U test.
 Results 
 Morphology 
 The overall morphology of TEM was assessed by
hematoxylin-eosin staining. The newly developed TEM 
construct had a well-developed, multilayered and strati-
fied squamous epithelium, consisting of a basal, inter-
Antibody Concentration Source
Collagen type IV 1/500 Euro-Diagnostica, Nijmegen, The Netherlands
Desmoglein-3 1/500 Novus Biologicals, LLC., Littleton, Colo., USA
Integrin 6 1/1,000 Novus Biologicals, LLC., Littleton, Colo., USA
Integrin 4 1/2,000 Novus Biologicals, LLC., Littleton, Colo., USA
Involucrin 1/500 Novus Biologicals, LLC., Littleton, Colo., USA
K10 1/200 Euro-Diagnostica, Nijmegen, The Netherlands
K13 1/200 Euro-Diagnostica, Nijmegen, The Netherlands
K19 1/500 Novus Biologicals, LLC., Littleton, Colo., USA
Ki67 1/200 DAKO, Glostrup, Denmark
Laminin-5 1/1,000 Abcam, Cambridge, Mass., USA
Vimentin 1/200 Euro-Diagnostica, Nijmegen, The Netherlands
Table 1.  Primary antibodies used for 
immunohistochemistry
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mediate and superficial layer ( fig.  1 a) and resembles 
NNOM ( fig. 1 b). The epidermis of TEM was parakera-
tinized, as pyknotic cells were present in the epithelial 
layer. The basal layer was neatly arranged in two to three 
layers with cuboidal-shaped cells. The epidermal layer of 
NNOM has an average thickness of 194.3  8 59.3   m and 
is significantly thicker compared to the epidermis of 
TEM, which has an average thickness of 72.6  8 26.9   m 
( fig. 1 c) (p  ! 0.001). Vacuoles were observed in the epi-
thelial cells in the intermediate layer of NNOM and 
TEM. The glycogen content in NNOM was indicated by 
PAS staining, showing glycogen in the intermediate lay-
er ( fig. 1 e). PAS staining was also present in the interme-
diate layer in TEM albeit less intense than in NNOM 
( fig. 1 d).
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 Fig. 1. Hematoxylin-eosin staining of a cross section of TEM ( a ) 
and NNOM ( b ). TEM resembles overall morphology of NNOM, 
and shows a well-formed, multilayered, parakeratinized epider-
mis. The epidermis was significantly thinner in TEM (72.6  8 
26.9   m) when compared to NNOM (194.3  8 59.3   m). Data are 
presented as mean  8 SD ( * * * p  ! 0.001) ( c ). The keratinocytes in 
the intermediate layer seemed to have vacuoles. PAS staining 
showed lower glycogen content in TEM ( d ) compared with 
NNOM ( e ). All pictures are representative for the staining per-
formed. Scale bars = 100   m. 
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 Epidermal Differentiation 
 Keratin expression in the epidermis was assessed by 
staining for K10, K13 and K19. TEM showed expression 
of K10 in the superficial layer only, whereas no expression 
of K10 was seen in NNOM ( fig. 2 a, b). K13 stained weak-
ly in the intermediate layer of TEM ( fig. 2 d), and in both 
the intermediate and superficial layers of the epithelium 
of NNOM ( fig. 2 e). Expression of K19 was observed in the 
basal layer only of the epithelium of TEM and NNOM 
( fig. 2 g, h). Close observation showed that not every bas-
al cell is positive for K19. Analysis of the basal layer of 
TEM and NNOM showed that TEM has an average of 
74.85  8 12.84 positive cells, which is significantly lower 
compared to NNOM (88.03  8 6.41; p  ! 0.001). Involucrin 
was observed in all layers except the basal layer in both 
TEM and NNOM ( fig. 2 j, k).
 Proliferation 
 Cells in the basal layer are typically the only cells that 
proliferate in the epithelium. Proliferation was assessed 
by Ki67, a protein present in all proliferating cells. In both 
TEM only ( fig. 3 a) and NNOM, proliferating cells were 
observed in the basal layer only ( fig. 3 b). The PI was sig-
nificantly lower in TEM (36.6  8 11.1) compared to 
NNOM (55.8  8 8.3) ( fig. 3 d) (p  ! 0.001).
 Connective Tissue 
 Fibroblasts are the predominant cell type in the der-
mal layer. The presence and distribution of fibroblasts 
were assessed by vimentin staining. In TEM, fibroblasts 
were found in the lamina propria, where they were main-
ly located on the bottom surface of the lamina propria 
( fig. 3 e). In NNOM, the fibroblasts were found distrib-
uted homogeneously in the connective tissue ( fig. 3 f).
 Basement Membrane 
 The presence of BM components collagen type IV and 
laminin-5 were first determined in the DED scaffold. 
Collagen type IV is a component of basal lamina and 
laminin-5 is a component of the anchoring filaments. 
Both components were expressed in the scaffold along 
the whole dermal-epidermal junction before seeding of 
fibroblasts and keratinocytes ( fig. 4 a–e). The expression 
of collagen type IV and laminin-5 was restricted to the 
BM. The addition of fibroblasts and keratinocytes did not 
alter the expression of collagen type IV ( fig. 4 b) or lam-
inin-5 ( fig. 4 f) in TEM. Collagen type IV expression was 
higher in TEM ( fig. 4 b) than in NNOM ( fig. 4 c). Lam-
inin-5 was more abundantly expressed in NNOM ( fig.
4 g) than in TEM ( fig. 4 f).
 Dermal-Epidermal Junction 
 Desmosomes and hemidesmosomes are responsible 
for cell-cell attachment and the attachment of the epithe-
lial layer to the underlying connective tissue. Cell-cell 
attachment by desmosomes was assessed by desmo-
glein-3, a glycoprotein component of desmosomes. Cells 
in the basal and intermediate layer of TEM and NNOM 
were equally positive for desmoglein-3 ( fig. 5 a, b). Before 
the seeding of fibroblasts and keratinocytes, the hemides-
mosomal subunits integrin   6 and   4 were not present 
in the DED scaffold ( fig. 5 d, e). Integrin   6 was expressed 
along the whole dermal-epidermal junction, predomi-
nantly in the BM, in both TEM ( fig.  5 f) and NNOM 
( fig.  5 e). Integrin   4 was also present along the whole 
dermal-epidermal junction, predominantly in the BM of 
both TEM and NNOM, although the intensity of inte-
grin   4 was lower in TEM compared to NNOM. In all 
sections used, the newly formed epithelium was attached 
to the underlying connective tissue and detachment was 
never seen.
 Discussion 
 The aim of this study was to create a mucosal con-
struct that resembles native oral mucosa. Therefore, we 
engineered TEM by seeding oral keratinocytes and fibro-
blasts onto DED. Next, TEM and NNOM were compared 
on epidermal structure, BM and underlying connective 
tissue organization. Here we show an oral mucosal con-
struct composed of a multilayered epithelium with many 
morphological and immunological characteristics ob-
served in NNOM. No morphological differences were 
observed between the TEM constructs from different do-
nors. K19, Ki67, involucrin, integrin   6 and   4, vimentin, 
collagen type IV and laminin-5 were present in our TEM 
construct ( table 2 ). Overall morphology of TEM was ob-
served to be similar to NNOM, although the epidermal 
layer of TEM was found to be significantly thinner com-
pared to NNOM. Despite the epidermis being thinner in 
TEM, essential components such as a BM, a proliferating 
basal layer and a differentiated epidermis were present in 
the epidermal layer and resembled NNOM. The presence 
of involucrin, a marker for terminal differentiation [Ala-
minos et al., 2007], demonstrated that a mature epitheli-
um was formed in TEM. The DED scaffold used in this 
study was chosen for its easy handling, noncontractile 
nature and firmness. The scaffold has to be able to with-
stand mechanical stress, as the oral mucosa is continu-
ously exposed to some degree of mechanical stress [Pres-
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 Fig. 2. Keratin expression was assessed in TEM and NNOM. K10, 
present in keratinized mucosa, was present in the superficial layer 
of the epidermis of TEM ( a ) but was not observed in NNOM ( b ). 
K13, present in nonkeratinizing epithelium, was weakly expressed 
in  TEM ( d ) but was strongly expressed in NNOM ( e ). K19, present 
in the basal layer of nonkeratinizing epithelium of the oral cavity, 
was observed in the basal layer of TEM ( g ) and NNOM ( h ). The 
expression pattern of involucrin in TEM ( j ) proved to be similar to 
NNOM ( k ).  c ,  f ,  i ,  l Negative controls of all stainings are included. 
All pictures are representative for the stainings. Scale bars = 100 
  m. 
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land and Jurevic, 2002]. We also found the presence of 
BM components an advantage as the BM connects the 
epithelium to the underlying connective tissue. The seed-
ed cells do not have to deposit these BM components 
themselves before developing the new epithelial layer.
 The oral epithelium generally has a high number of 
proliferating cells. In buccal mucosa the turnover rate is 
approximately 2–3 times that of the epidermis of the skin 
[Winning and Townsend, 2000], and a PI of 58.8 has been 
reported in native buccal mucosa [van Oijen et al., 1998]. 
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 Fig. 3. Cell proliferation in TEM ( a ) was compared to NNOM ( b ). 
Proliferating cells were only observed in the basal layer of both 
NNOM and TEM. The number of proliferating cells in TEM (36.6 
 8 11.1) was significantly lower compared to NNOM (558  8 8.3). 
Data are presented as mean  8 SD ( * * * p  ! 0.001) ( d ). Fibroblast 
distribution was assessed by vimentin staining. In TEM, fibro-
blasts (indicated by arrows) were seen only on the lower surface 
of the lamina propria ( e ), whereas in NNOM, fibroblasts were 
seen throughout the connective tissue ( f ). Negative controls of 
both stainings are included ( c ,  g ). All pictures shown are repre-
sentative for the stainings. Scale bars = 100   m. 
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 Fig. 4. BM components collagen type IV ( a ) and laminin-5 ( e ) were present in the DED scaffold before seeding of 
keratinocytes and fibroblasts. Collagen type IV and laminin-5 were equally expressed in TEM ( b ,  f ) and NNOM 
( c ,  g ). Negative controls are included ( d ,  h ). All pictures shown are representative for the stainings. Scale bars = 
100   m. 
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 Fig. 5. Cell-cell adhesion was assessed by desmoglein-3, a gly-
coprotein of desmosomes. In both TEM ( a ) and NNOM ( b ) des-
moglein-3 was observed in the basal layers of the epidermis.
Hemi-desmosomal subunits   6 and   4 were not expressed in the 
DED scaffold ( d ,  e ). A similar expression pattern for integrin   6
was observed in TEM ( f ) and NNOM ( g ). Integrin   4 expression 
was seen in the basal layer of TEM ( i ) and NNOM ( j ), although
the intensity in TEM was lower than in NNOM.  c ,  h ,  k Negative 
controls are included. All pictures shown are representative for 
the stainings. Scale bars = 100   m. 
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After 3 weeks of culture, our TEM model showed prolif-
erating cells in the basal layer of the construct, indicating 
a self-renewal capacity of TEM. The PI of TEM was found 
to be significantly lower than that of NNOM. The lower 
PI of TEM was in accordance with the lower staining in-
tensity of PAS indicating less glycogen storage in TEM 
than in NNOM. Many differences have been reported 
about the number of proliferating cells in mucosal equiv-
alents. Some studies report hyperproliferation [Chung et 
al., 1997; Izumi et al., 2004], slightly reduced proliferation 
[Kinikoglu et al., 2009] or strongly reduced to no prolif-
eration [Pena et al., 2010]. It has been shown that the 
number of keratinocytes expressing Ki67 progressively 
decreases over time, showing maximum proliferative ca-
pacity in the first week of culture which decreases to a few 
cells at the end of the third week of culture [Tomakidi et 
al., 1998; Kinikoglu et al., 2009]; the latter is in accor-
dance with our observations. The discrepancies between 
the studies might be a result of the differences in scaffold, 
which varies from DED to fibrin, and the composition of 
the culture media used to construct the mucosal substi-
tutes, which are very variable between different studies.
 Keratins are the predominant cytoskeletal proteins in 
epithelia, and depending on the stage of differentiation 
and cell type different cytokeratins are expressed [Pres-
land and Jurevic, 2002]. The differentiation pattern of our 
TEM construct was assessed by K10, K13 and K19. K19 
was observed in the majority of the cells of the basal layer 
of the epithelium of TEM, indicating a nonkeratinizing 
nature of the epithelium of our construct. K13, a keratin 
present in the intermediate and superficial layer of the 
nonkeratinizing epithelium, was weakly expressed in 
TEM. Interestingly, K10, an early differentiation marker 
of keratinizing epithelium, was found to be expressed in 
the superficial layer of the epidermis in TEM, which is 
unusual as K10 is normally expressed in the spinous lay-
er of keratinizing epithelia. We hypothesize that this K10 
expression in the superficial layer of TEM is the result of 
the fact that we handle TEM gently and apply minimal 
mechanical trauma, meaning that this layer was never 
rubbed off, as would happen in native oral epithelium.
 Previous studies have shown that connective tissues 
are responsible for the final pattern of oral epithelium 
differentiation [Karring et al., 1975; Mackenzie and Hill, 
1984; Chung et al., 1997]. The DED scaffold used to create 
the TEM construct originates from donor skin, which 
might explain the keratin expression pattern in TEM. 
The use of fibroblasts taken from buccal mucosa incor-
porated in TEM did not lead to direct expression of K13. 
This suggests that the connective tissue has a higher in-
fluence on the differentiation pattern of the epidermis 
than the incorporated fibroblasts or the seeded keratino-
cytes. This finding is in line with a study by Rakhorst et 
al. [2006] which showed that incorporation of fibroblasts 
in TEM did not affect the differentiation pattern of the 
keratinocytes. In addition, other studies suggested that 
intrinsic and extrinsic factors influence the differentia-
tion process of the epithelium and that the expression of 
K10 and K13 might be determined by the connective tis-
sue, whereas K19 expression might be determined by the 
epithelium [Kautsky et al., 1995]. Another explanation for 
the differences in keratin expression could be the location 
of the fibroblasts; keratin expression may vary with the 
distribution of fibroblasts which are, in the TEM model, 
not present close to the epithelium.
 In this study, the presence and distribution of fibro-
blasts in TEM and NNOM was assessed by vimentin 
staining. In TEM, fibroblasts were found to be on the low-
er half of the connective layer, whereas in NNOM they are 
dispersed homogenously in the connective layer. Several 
studies have shown the necessity of incorporating fibro-
blasts into the scaffold for epidermal development, as 
they stimulate keratinocyte proliferation and migration 
[El Ghalbzouri et al., 2002a; Rakhorst et al., 2006]. In
addition, the presence of fibroblasts is known to lead
to a well-developed epidermal layer as these cells secrete 
growth factors, and the paracrine cross talk between ke-
ratinocytes and fibroblasts is essential for the formation 
of a new epidermis [El Ghalbzouri and Ponec, 2004]. Even 
Table 2.  Summary of epidermal characteristics of TEM and 
NNOM
E pidermis
TE M NNOM
Tissue architecture BL, IL, SL BL, IL, SL
Number of living cell layers 5–10 15–20
K10 SL absent
K13 SL IL, SL
K19 BL BL
Ki67 BL, ++ BL, ++++
Desmoglein-3 BL, IL BL, IL
Integrin 6 BL BL
Integrin 4 BL BL
Collagen type IV BL BL
Laminin-5 BL BL
Involucrin BL, IL, SL BL, IL, SL
BL = Basal layer; IL = intermediate layer; SL = superficial layer.
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though the fibroblasts were not homogenously distrib-
uted in TEM, the construct displays a well-developed, 
multilayered epidermis.
 Cell-cell adhesion and attachment of the epidermal 
layer to the connective tissue are essential for correct 
functionality of NNOM and therefore also for mucosal 
substitutes [Green and Jones, 1996; Presland and Jurevic, 
2002]. Desmosomes are complexes that link the keratino-
cytes to each other. An important component of desmo-
somes is the protein desmoglein-3. Immunohistochemis-
try proved that desmoglein-3 was present in TEM and a 
similar expression pattern was found in NNOM. This 
suggests that the cells were actively synthesizing compo-
nents to ultimately form desmosomes for cell-cell adhe-
sion to maintain structural stability and functionality. 
Hemidesmosomes are responsible for the adhesion of the 
epithelial layer to the BM of the connective layer. Integrin 
  6 and   4, subunits of hemidesmosomes, were found to 
be similarly expressed in NNOM and TEM constructs. 
This corresponding expression of these integrins and 
desmosomal protein desmoglein-3 implies that TEM 
constructs form a number of proteins necessary for the 
formation of desmosomes and hemidesmosomes in order 
to form a tight barrier which mimics native oral mucosa 
and might also mimic its functionality. However, this 
specific aspect remains to be proven.
 The applications for TEM range from transplantation 
into the oral cavity to studying oral mucositis or fibrosis. 
These applications require further investigation. Before 
TEM can be used for transplantation, we have to test it in 
vivo to determine the quality of TEM posttransplanta-
tion by, for example, assessing viability and angiogenesis. 
To study oral mucositis the TEM construct has to be ex-
tended as no immune cells are present in the current 
model. An addition of immune cells such as dendritic 
cells or Langerhans cells would be required [Bechetoille 
et al., 2007], or TEM could be treated with proinflamma-
tory cytokines modifying TEM to create an equivalent 
mimicking oral mucositis [Tjabringa et al., 2008].
 In summary, the TEM construct developed in this 
study resembles NNOM. TEM is an oral mucosal con-
struct composed of a multilayered epithelium with many 
morphological and immunological characteristics ob-
served in NNOM. Based on the results of this study, we 
are convinced that TEM holds promise for future re-
search, for example, the early mechanisms leading to oral 
mucositis and fibrosis.
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